Data Sheet
Goserelin Acetate - VitalDose® EVA Implant Feasibility

VitalDose® EVA drug delivery platform can deliver reliable controlled release performance in long-acting therapeutic applications. In this feasibility study, we highlight the release characteristics of the peptide goserelin acetate in VitalDose® EVA. Learn more about release profiles for both monolithic and multilayer implant designs with demonstrated API stability data for up to 176 days release. Biodurable implants can enhance long-acting control of your peptide therapeutic treatment and increase patient compliance.

Download the data sheet now

Celanese BioPolymer Solutions
The Best Packaging Solutions Begin + Return to Nature


This website uses 'cookies' to give you the best, most relevant experience. Using this website means you are Ok with this. You can change which cookies are set at any time - and find out more about them - by following this link.

Information on the processing of your personal data within the USA by Google and Marketo:
By clicking "Accept All", or selecting "Marketing" and/or "Analytical" and then clicking "Accept Selected", you also consent in accordance with Art. 49(1)(a) GDPR that your data may be processed in the USA. The USA is considered by the European Court of Justice to be a country with no adequate level of data protection according to EU standards. In particular, there is a risk that your data may be processed by US authorities for surveillance and investigation purposes, possibly without the opportunity for legal remedies. If you select “Necessary” and then click on "Accept Selected”, the transfer described above will not take place. You will find more detailed information in our privacy policy.